patients with cardiovascular disease

WASHINGTON (MedPage Today) -- The FDA has updated the label for varenicline (Chantix), the smoking cessation drug, with additional safety and efficacy information in patients with cardiovascular disease or chronic obstructive pulmonary disease (COPD).

NEW ORLEANS (MedPage Today) -- A restrictive transfusion policy reduced blood use by 50% and posed no increased hazards to older patients with cardiovascular disease who were undergoing surgery for hip fracture, data from an NIH-funded study showed.

(Cardiovascular Research Foundation) Results from a late breaking clinical trial called COGENT demonstrate that the combination of giving patients clopidogrel, a blood thinner commonly prescribed to patients with cardiovascular disease, and stomach medicines such as omeprazole, known as proton pump inhibitors, did not lead to adverse events, as some prior studies had suggested.

The results were presented at the 21st annual Transcatheter Cardiovascular Therapeutics scientific symposium, sponsored by the Cardiovascular Research Foundation.